Table 3 Distribution and proportion of HPV genotypes in ASCUS, L-SIL, and H-SIL cytological lesions
From: HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
| Â | Cytology result, N (%) | |||
|---|---|---|---|---|
Genotypes | ASCUS (NÂ =Â 188) | L-SIL (NÂ =Â 61) | H-SIL (NÂ =Â 19) | Totala (%) |
HR-HPV | Â | |||
 HPV16 | 26 (13.8%) | 12 (19.7%) | 3 (15.8%) | 41 (15.3%) |
 HPV18 | 8 (4.3%) | 2 (3.3%) | 1 (5.3%) | 11 (4.1%) |
 HPV31 | 31 (16.5%) | 7 (11.5%) | 2 (10.5%) | 40 (14.9%) |
 HPV33 | 4 (2.1%) | 2 (3.3%) | 0 (0%) | 6 (2.2%) |
 HPV35 | 3 (1.6%) | 1 (1.6%) | 0 (0%) | 4 (1.5%) |
 HPV39 | 5 (2.7%) | 2 (3.3%) | 0 (0%) | 7 (2.6%) |
 HPV45 | 5 (2.7%) | 1 (1.6%) | 2 (10.5%) | 8 (3%) |
 HPV51 | 11 (5.9%) | 1 (1.6%) | 1 (5.3%) | 13 (4.9%) |
 HPV52 | 0 (0%) | 2 (3.3%) | 2 (10.5%) | 4 (1.5%) |
 HPV56 | 3 (1.6%) | 6 (9.8%) | 0 (0%) | 9 (3.4%) |
 HPV58 | 18 (9.6%) | 2 (3.3%) | 0 (0%) | 20 (7.5%) |
 HPV59 | 3 (1.6%) | 1 (1.6%) | 0 (0%) | 4 (1.5%) |
 HPV68 | 8 (4.3%) | 5 (8.2%) | 1 (5.3%) | 14 (5.2%) |
LR-HPV | Â | |||
 HPV6 | 15 (8%) | 7 (11.5%) | 2 (10.5%) | 24 (9%) |
 HPV11 | 2 (1.1%) | 1 (1.6%) | 0 (0%) | 3 (1.1%) |
 HPV42 | 9 (4.8%) | 1 (1.6%) | 0 (0%) | 10 (3.7%) |
 HPV44 | 1 (0.5%) | 1 (1.6%) | 1 (5.3%) | 3 (1.1%) |
 HPV53 | 21 (11.2%) | 5 (8.2%) | 1 (5.3%) | 27 (10.1%) |
 HPV54 | 6 (3.2%) | 1 (1.6%) | 2 (10.5%) | 9 (3.4%) |
 HPV55 | 4 (2.1%) | 0 (0%) | 1 (5.3%) | 5 (1.9%) |
 HPV61 | 11 (5.9%) | 3 (4.9%) | 0 (0%) | 14 (5.2%) |
 HPV66 | 8 (4.3%) | 7 (11.5%) | 0 (0%) | 15 (5.6%) |
 HPV70 | 2 (1.1%) | 1 (1.6%) | 0 (0%) | 3 (1.1%) |
 HPV73 | 2 (1.1%) | 3 (4.9%) | 0 (0%) | 5 (1.9%) |
 HPV81 | 3 (1.6%) | 0 (0%) | 0 (0%) | 3 (1.1%) |
 HPV82 | 6 (3.2%) | 0 (0%) | 0 (0%) | 6 (2.2%) |
 HPV89 | 4 (2.1%) | 1 (1.6%) | 1 (5.3%) | 6 (2.2%) |
UR-HPV | ||||
 HPV34 | 0 (0%) | 1 (1.6%) | 0 (0%) | 1 (0.4%) |
 HPV62 | 1 (0.5%) | 3 (4.9%) | 0 (0%) | 4 (1.5%) |
 HPV83 | 5 (2.7%) | 0 (0%) | 1 (5.3%) | 6 (2.2%) |
 HPV84 | 5 (2.7%) | 1 (1.6%) | 2 (10.5%) | 8 (3%) |
 HPV90 | 0 (0%) | 1 (1.6%) | 0 (0%) | 1 (0.4%) |
 HPV91 | 1 (0.5%) | 0 (0%) | 0 (0%) | 1 (0.4%) |